United States · Bill · HR
H.R. 349 (117th)
Coronavirus Vaccine and Therapeutic Development Act of 2021
Introduced
19 January 2021
Last action
—
Status
Sponsor introductory remarks on measure. (CR H393)
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
Coronavirus Vaccine and Therapeutic Development Act of 2021 This bill directs the Department of Health and Human Services (HHS) to increase the supply of vaccines and medical products that prevent or control COVID-19 (i.e., coronavirus disease 2019). To increase supplies, HHS must, as appropriate, award grants and enter other transactions to expand relevant research, procurement, and production activities. HHS must report to Congress on these actions. The report must assess and detail plans to enhance the supply chain and manufacturing capacity for the vaccines and products. It must also include plans to support domestic and international vaccination programs.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 19 January 2021
Introduced in House (PDF)
Introduced in House · EN · 19 January 2021
Introduced in House
summary · EN · 19 January 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/349
- Open data entity: https://api.congress.gov/v3/bill/117/hr/349